Plain-English translation of NCT06857942 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Psoriasis research guide โPhase 4 โ The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing , a medication that helps with weight loss, when added to ixekizumab, a treatment you're already receiving for moderate-to-severe psoriasis. Researchers want to see whether the medication can help improve both your skin condition and your weight over the course of a year. This study is happening in real-world clinical practice, meaning it reflects how doctors would actually treat patients like you.
Many people with severe psoriasis also struggle with weight or obesity, which can make their skin condition worse and increase other health risks. Researchers believe that adding a weight-loss medication alongside psoriasis treatment might improve both conditions at the same time, but this approach needs to be tested to confirm it works safely and effectively.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will continue taking your psoriasis medication (ixekizumab) and begin taking the weight-loss medication () as an injection under the skin, following your doctor's instructions. The study lasts up to 12 months, and you'll have regular visits with your healthcare team to check how well the treatment is working, monitor your skin and weight, and watch for any side effects. You'll track your psoriasis symptoms, weight changes, and overall health throughout the year.
AI-generated summary from trial data ยท Jun 2, 2026 ยท Not medical advice
United States